MEMPHASYS LTD Total Liabilities
MEMPHASYS LTD total liabilities. Based on the latest financial reports, MEMPHASYS LTD (IG7) has total liabilities worth €5.59 Million EUR (≈ $6.54 Million USD) as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See IG7 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Total Liabilities of MEMPHASYS LTD (2021–2024)
Total liabilities of MEMPHASYS LTD from 2021 to 2024. This chart illustrates how MEMPHASYS LTD's total liabilities have evolved over time, based on quarterly financial data. Explore IG7 long-term investments to assets to see how much of total assets are deployed in long-term investments.
MEMPHASYS LTD Competitors by Total Liabilities
The table below lists competitors of MEMPHASYS LTD ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MANTLE MINERALS
F:MXB0
|
Germany | €871.45K |
|
Spineway
PA:ALSPW
|
France | €6.40 Million |
|
Casa Emtia Petrol Kimyevi ve Turevleri Sanayi ve Ticaret AS
IS:CASA
|
Turkey | TL82.96 Million |
|
Pacific Strategic Financial
JK:APIC
|
Indonesia | Rp4.41 Trillion |
|
Adalta Ltd
AU:1AD
|
Australia | AU$2.07 Million |
|
Sparta Capital Ltd
V:SAY
|
Canada | CA$3.68 Million |
|
Aro Granite Industries Limited
NSE:AROGRANITE
|
India | Rs2.20 Billion |
|
DOREL INDS INC. A
F:DO4C
|
Germany | €823.37 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down MEMPHASYS LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of MEMPHASYS LTD.
Liquidity & Leverage Metrics
MEMPHASYS LTD Total Liabilities Ratios Explained
MEMPHASYS LTD total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MEMPHASYS LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MEMPHASYS LTD (2021–2024)
The table below shows the annual total liabilities of MEMPHASYS LTD from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | €5.59 Million ≈ $6.54 Million |
-23.21% |
| 2023-06-30 | €7.28 Million ≈ $8.51 Million |
+12.49% |
| 2022-06-30 | €6.47 Million ≈ $7.57 Million |
+8.38% |
| 2021-06-30 | €5.97 Million ≈ $6.98 Million |
-- |
About MEMPHASYS LTD
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, an in-vitro diagnostic device; and AI-Port, an ambie… Read more